# Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma

> **NCT00002748** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 38 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** gene-modified tumor cell vaccine therapy
- **BIOLOGICAL:** interleukin-2 gene

## Key facts

- **NCT ID:** NCT00002748
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-12
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2011-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002748, "Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00002748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*